Glenmede Trust’s Loxo Oncology, Inc LOXO Stock Holding History

Glenmede Trust’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,145	Closed	-$159	–	3261
2018 Q4	$159	Buy	1,145 +105	+10%	+$15.9K	﹤0.01%	1195
2018 Q3	$176K	Buy	1,040 +50	+5%	+$8.4K	﹤0.01%	1188
2018 Q2	$172K	Buy	+990	New	+$149K	﹤0.01%	1104
2016 Q3	–	Sell	-115	Closed	-$2K	–	2729
2016 Q2	$2K	Sell	115 -175	-60%	-$4.36K	﹤0.01%	2422
2016 Q1	$7K	Hold	290	–	–	﹤0.01%	2148
2015 Q4	$8K	Hold	290	–	–	﹤0.01%	2149
2015 Q3	$5K	Hold	290	–	–	﹤0.01%	2326
2015 Q2	$5K	Buy	+290	New	+$3.96K	﹤0.01%	2252

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Glenmede Trust's LOXO Position: Q1 2019 in Review

Glenmede Trust sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 1,145 shares — an estimated $159 sold.

Glenmede Trust first reported a position in LOXO in Q2 2015 and held it in 8 quarters. The position peaked at $176K in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Glenmede Trust reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Glenmede Trust sold 1,145 Loxo Oncology, Inc shares in Q1 2019, an estimated $159.
Glenmede Trust first reported a position in Loxo Oncology, Inc in Q2 2015 and held it in 8 quarters.
Glenmede Trust's Loxo Oncology, Inc position peaked at $176K in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Glenmede Trust's 13F filing for Q1 2019, filed 14 May 2019.